Indaptus Therapeutics, Inc.
INDP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857044
No open-market purchases or sales by Indaptus Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q3 2026, worth $2.18M in total; no superinvestor holds it.
Holders of 5% or more of INDP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Indaptus Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Lazar David E. | 13D/A | 47.93%2.06M shares | −50.07 ppfrom 98.00% | Mar 2, 20262 filings | Mar 24, 2026 | SEC |
| Yao Yun | 13D/A | 27.34%42.0M shares | −4.17 ppfrom 31.51% | Mar 30, 20264 filings | Oct 22, 2026 | SEC |
| Sino Lion Ventures Ltd | 13D/A | 25.32%38.9M shares | −3.87 ppfrom 29.19% | Jun 26, 20262 filings | Oct 22, 2026 | SEC |
| Meckler Jeffrey A | 13D/A | 12.70%273.1K shares | – | Oct 10, 20243 filings | Dec 30, 2025 | SEC |
| Dai Junyi | 13D/A | 7.33%11.3M shares | −1.11 ppfrom 8.44% | Jun 26, 20262 filings | Oct 22, 2026 | SEC |
| Yang Ting | 13D/A | 6.48%9.95M shares | −1.96 ppfrom 8.44% | Jun 26, 20262 filings | Oct 21, 2026 | SEC |
| Newman Michael James | 13D/A | 5.40%115.6K shares | – | Aug 13, 20213 filings | Dec 30, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
28 Schedule 13D and 13G filings on Indaptus Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 22, 20264:06 PM ET | Sino Lion Ventures Ltdand 1 other | 13D/A | 25.32%38.9M shares | −3.87 ppfrom 29.19% | Oct 16, 2026 | SEC |
| Oct 22, 20264:05 PM ET | Dai Junyi | 13D/A | 7.33%11.3M shares | −1.11 ppfrom 8.44% | Oct 16, 2026 | SEC |
| Oct 22, 20264:05 PM ET | Yao Yun | 13D/A | 27.34%42.0M shares | −4.17 ppfrom 31.51% | Oct 16, 2026 | SEC |
| Oct 21, 20264:05 PM ET | Yang Ting | 13D/A | 6.48%9.95M shares | −1.96 ppfrom 8.44% | Oct 16, 2026 | SEC |
| Jun 26, 20269:40 PM ET | Sino Lion Ventures Ltdand 1 other | 13D/A | 29.19%38.9M shares | – | Jun 24, 2026 | SEC |
| Jun 26, 20268:00 PM ET | Dai Junyi | 13D/A | 8.44%11.3M shares | – | Jun 24, 2026 | SEC |
| Jun 26, 20268:00 PM ET | Yang Ting | 13D/A | 8.44%11.3M shares | – | Jun 24, 2026 | SEC |
| Jun 26, 20268:00 PM ET | Yao Yun | 13D/A | 31.51%42.0M shares | −5.59 ppfrom 37.10% | Jun 24, 2026 | SEC |
| Apr 29, 20264:05 PM ET | Yao Yunand 5 others | 13D/A | 37.10%42.0M shares | −0.70 ppfrom 37.80% | Apr 28, 2026 | SEC |
| Apr 6, 20264:40 PM ET | YA II PN, Ltd.and 7 others | 13G/A | 0.00%0 shares | −9.99 ppfrom 9.99%Below 5% | Dec 31, 2025 | SEC |
| Mar 30, 20269:46 PM ET | Yao Yunand 5 others | 13D | 37.80%42.0M shares | New | Mar 23, 2026 | SEC |
| Mar 24, 20264:05 PM ET | Lazar David E. | 13D/A | 47.93%2.06M shares | −50.07 ppfrom 98.00% | Mar 23, 2026 | SEC |
| Mar 2, 20265:20 PM ET | Lazar David E. | 13D | 98.00%111.0M shares | New | Feb 26, 2026 | SEC |
| Dec 30, 20254:01 PM ET | Meckler Jeffrey A | 13D/A | 12.70%273.1K shares | – | Dec 22, 2025 | SEC |
| Dec 30, 20254:01 PM ET | Newman Michael James | 13D/A | 5.40%115.6K shares | – | Dec 22, 2025 | SEC |
| Feb 18, 20254:03 PM ET | YA II PN, Ltd.and 7 others | 13G | 9.99%1.41M shares | New | Feb 13, 2025 | SEC |
| Nov 26, 2024 | Meckler Jeffrey A | 13D/AOld format | – | – | – | SEC |
| Oct 10, 2024 | Meckler Jeffrey A | 13DOld format | – | New | – | SEC |
| Aug 17, 2023 | Anderson Glen R. | 13G/AOld format | – | – | – | SEC |
| Jul 8, 2022 | Anderson Glen R. | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Intracoastal Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 17, 2021 | Anderson Glen R. | 13D/AOld format | – | – | – | SEC |
| Oct 26, 2021 | Newman Michael James | 13D/AOld format | – | – | – | SEC |
| Oct 26, 2021 | Lee Hoonmo | 13D/AOld format | – | – | – | SEC |
| Oct 26, 2021 | Anderson Glen R. | 13D/AOld format | – | – | – | SEC |
| Aug 19, 2021 | Anderson Glen R. | 13DOld format | – | New | – | SEC |
| Aug 13, 2021 | Lee Hoonmo | 13DOld format | – | New | – | SEC |
| Aug 13, 2021 | Newman Michael James | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Indaptus Therapeutics, Inc. shares.
No Form 144 notices for Indaptus Therapeutics, Inc. are on file.